Complain about a product or service

Merck Recalls Children's Vaccines

Possible sterilization problems with 1.2 million doses

December 13, 2007    Spanish

Drug Safety • FDA Wants Black Box Warning on Antibiotics • Public Citizen Sues FDA for Failure to Act on Darvon • FDA Probes Arthritis Drug Link To Cancer • FDA Wants New Labeling Rules To Protect Pregnant, Nursing Women • Anti-Smoking Drug Chantix Linked to Seizures, Heart Problems, Diabetes • Bayer Pulls Trasylol From Market • MIT Researchers Confirm Contamination in Heparin • Be Careful Using Over-the-Counter Creams, Ointments • Another Heparin Producer Announces a Recall • FDA Moves Closer To Setting Up Shop In China • Study Raises Concerns About Anemia Drugs • Congress Hears Warnings about FDA • China Connection in Heparin Problems? • Heparin Linked to Severe Allergic Reactions • Antibiotic Leads to Tendon Ruptures • Second Safety Warning on Fentanyl Skin Patch • Merck Recalls Children's Vaccines • Study: Avandia May Do More Harm than Good • Texas Sues Drug Manufacturer Blamed for West Coast Deaths • Bayer Withdraws Antibleeding Drug Trasylol --- • More drug safety news ...

Merck & Co. is recalling about 1.2 million doses of its widely-used children's vaccines because of concerns that production equipment may not have been properly sterilized.

The recalled vaccines protect against a form of Influenza Type B, commonly known as Hib disease, which was once the leading cause of bacterial meningitis in young children, the U.S. Centers for Disease Control and Prevention said.

Merck said that 11 lots of PedvaxHIB vaccine and two lots of its Comvax vaccine were included in the recall. Both protect against Hib. Comvax also prevents hepatitis B.

The vaccines were manufactured in West Point, Pennsylvania, and distributed starting in April 2007. All but one lot was distributed in the United States, the company said.

Sterility tests found no contamination, Merck said, but quality-control tests found that some of the production equipment at the West Point plant may not have been properly sterilized.

"The potential for contamination of any individual vaccine is low, and, if present, the level of contamination would be low," Merck said.

Children who have received the affected vaccine do not need to be revaccinated because efficacy was not compromised, said Dr. Anne Schuchat, director of the CDC's National Center for Immunization and Respiratory Diseases.

She advised parents to look for signs of infection at the site of the inoculation in the days following the injection.

Here is a complete list of the vaccines being recalled:

Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.